Alpine Global Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-150,000
| Closed | -$102K | – | 427 |
|
|
2020
Q4 | $102K | Sell |
150,000
-602,739
| -80% | -$410K | 0.02% | 156 |
|
|
2020
Q3 | $1.69M | Buy |
752,739
+229,811
| +44% | +$517K | 0.35% | 43 |
|
|
2020
Q2 | $1.87M | Buy |
522,928
+97,928
| +23% | +$350K | 0.33% | 55 |
|
|
2020
Q1 | $1.62M | Buy |
425,000
+250,550
| +144% | +$952K | 0.34% | 42 |
|
|
2019
Q4 | $528K | Buy |
+174,450
| New | +$528K | 0.11% | 131 |
|